Skip to content
General News, Medical Health Aged Care

6 Key Breast Cancer Drugs Now More Affordable Thanks to 60-day Prescribing

Breast Cancer Network Australia 2 mins read


Breast Cancer Network Australia (BCNA) welcomes six common drugs used to treat breast cancer being able to be prescribed and dispensed for 60-days with a single prescription.  

The drugs include common types of hormone blocking therapies such letrozole, anastrozole and tamoxifen, amongst others, which combined represented almost one million individual prescriptions in the 2023 calendar year.  

These drugs are included in the second tranche of over 300 medicines that have moved to 60-day prescribing since it was announced in September last year.  

The six hormone blocking drugs are used to treat hormone receptor positive breast cancer. Hormone blocking therapy, also called endocrine therapy, works by blocking hormones that can cause cancer to grow or to come back. Around two thirds of all breast cancer diagnoses are hormone-receptor positive. 

BCNA Director Policy, Advocacy & Support Services Vicki Durston said allowing these vital drugs to be prescribed for 60-days at a time could save consumers hundreds of dollars.  

“It is especially important that we work to reduce the cost of hormone blocking therapies for breast cancer as some are required for ten years or more after active treatment finishes,” Ms Durston said.  

Jodi Steel, a BCNA Consumer Representative who was diagnosed with breast cancer in 2016, has been using hormone blocking therapies including tamoxifen and exemestane for seven years.   

“Sixty-day prescriptions essentially halves the cost of this treatment for me, which people like me with breast cancer need to take for a long period of time, to reduce the risk of our breast cancers recurring or progressing. 

“This will also help alleviate other ongoing costs, such as reducing the number of GP visits we require, and saving time spent refilling prescriptions,” Ms Steel said.  

In its 2017 report on the financial impacts of breast cancer, BCNA reported average out-of-pocket cost relating to breast cancer at around $5,000, but with some as high as $21,000.  

These figures do not include additional costs such as lost income, follow-up procedures, or paying for un-subsidised treatments. The situation for Australians with breast cancer is further exacerbated by the cost-of-living crisis.   

“Reducing the ongoing cost of these drugs is one way we can start to address financial toxicity and improve equity, especially for those in lower socioeconomic groups who already experience disparities in access to breast cancer care,” Ms Durston said.   

Last year, BCNA advocated strongly in support of 60-day prescribing alongside other groups such as the Royal Australian College of General Practitioners.  

Key Facts:

If you require quotes, content, or an interview please reach out and our team can coordinate this.

About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support.

Contact details:

Rachael Stewart | Media and Communications Manager | 03 9805 2540 | 

More from this category

  • Agriculture Farming Rural, General News
  • 25/04/2024
  • 11:40
Destination Scenic Rim

Scenic Rim Farm Gate Trail THIS SUNDAY

Grab your esky and your stretchy pants – the Scenic Rim Farm Gate Trail is THIS SUNDAY!! Overflowing larders right on the farm, freshly…

  • Contains:
  • Medical Health Aged Care
  • 25/04/2024
  • 09:05
Royal Australian College of GPs

More needs to be done for veterans missing out on care

More can be done to ensure veterans can access the care they need for chronic conditions, says the Royal Australian College of GPs (RACGP). In a submission to an independent evaluation of the Coordinated Veterans’ Care (CVC) Program, the peak body for GPs called for improvements to the scheme to help veterans access care. The CVC provides funding for care coordination in general practice for Veteran Gold Card holders with chronic conditions and Veteran White Card holders with chronic Department of Veterans Affairs (DVA)-accepted mental health conditions. RACGP President Dr Nicole Higgins said simple changes to the CVC would improve…

  • Education Training, Medical Health Aged Care
  • 24/04/2024
  • 16:17
La Trobe University

La Trobe awarded almost $1 million in research funding to improve antenatal care

A La Trobe University researcher has received almost $1 million in Federal Government funding to investigate ways to improve care for pregnant women. Six projects will share in $5 million from the National Health and Medical Research Council (NHMRC) Targeted Call for Research funding round, aimed at identifying how telehealth can be used most effectively and appropriately. Della Forster, Professor of Midwifery and Maternity Services Research with the Judith Lumley Centre and the Royal Women’s Hospital, received $999,585 for her team’s research into maternal and infant care. Professor Forster’s research looks at whether a combination of telehealth and face-to-face visits…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.